Nwf Advisory Services Inc. Gilead Sciences, Inc. Transaction History
Nwf Advisory Services Inc.
- $683 Billion
- Q4 2024
A detailed history of Nwf Advisory Services Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nwf Advisory Services Inc. holds 2,235 shares of GILD stock, worth $232,037. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,235Holding current value
$232,037% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,247Shares Held
998MCall Options Held
8.86MPut Options Held
8.69M-
Black Rock Inc. New York, NY121MShares$12.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.2 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.18 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.67 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.56 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...